Boxer Capital, LLC
SEC CIK 1465837 · EDGAR
BoughtSold
Most active insiders at TYRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MORE ROBERT J | Dir | — | $5.25M |
| 2 | Bensen Daniel | Chief Discovery Off | — | $4.81M |
| 3 | KAPLAN GILLA | Dir | — | $528.5K |
| 4 | Verjee Rehan | Dir | $20.0K | — |
| 5 | Rueb Yuliya | VP, Fin (PAO) | — | — |
| 6 | Warner Douglas J | Chief Medical Off | — | — |
| 7 | Ashar Bhavesh | COO | — | — |
| 8 | Harris Todd | Pres, CEO, Dir | — | — |
| 9 | Fuhrman Alan | CFO | — | — |
Boxer Capital, LLC made no open-market trades at TYRA in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-02-08 | 2024-02-06 | TYRA | Tyra Biosciences, Inc. | Boxer Capital, LLC | See Remarks | A - Grant | $13.01 | +63.4K | 85.9K | +281% | +$825.0K |
| M | 2022-10-13 | 2022-10-11+ | TNGX | Tango Therapeutics, Inc. | Boxer Capital, LLC | 10% | P - Purchase | $4.41 | +237.0K | 268.5K | +752% | +$1.04M |
| DM | 2021-09-17 | 2021-09-17 | TYRA | Tyra Biosciences, Inc. | Boxer Capital, LLC | 10% | C - Cnv Deriv | — | +5.99M | 288.1K | New | — |
| D | 2021-09-17 | 2021-09-17 | TYRA | Tyra Biosciences, Inc. | Boxer Capital, LLC | 10% | P - Purchase | $16.00 | +625.0K | 6.32M | +11% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations